<DOC>
	<DOC>NCT02272660</DOC>
	<brief_summary>Evaluated the effect of perioperative parecoxib administration on postoperative pain, analgesic use, function recovery, inflammatory response and bleeding risk.</brief_summary>
	<brief_title>Parecoxib for Pain Management After Total Knee Arthroplasty and Total Hip Arthroplasty</brief_title>
	<detailed_description>Non-steroid anti-inflammatory drugs are recommended for multimodal postoperative pain management. We evaluated the effect of perioperative parecoxib administration on postoperative pain, analgesic use, function recovery, inflammatory response and bleeding risk.</detailed_description>
	<mesh_term>Pain, Postoperative</mesh_term>
	<mesh_term>Parecoxib</mesh_term>
	<criteria>1. Male or female patients who have underwent primary unilateral total knee arthroplasty (TKA) and total hip arthroplasty (THA). 2. Age between 1865 years. 3. Chinese ethnicity. 1. patients who underwent a reversion or a previous TKA or THA, emergency TKA, or TKA as result of a trauma. 2. patient exhibited allergy to parecoxib sodium. 3. lactating or pregnant. 4. any other conditions not suitable for surgery as evaluated by the surgeon in charge.</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>65 Years</maximum_age>
	<verification_date>August 2015</verification_date>
	<keyword>preemptive analgesia</keyword>
	<keyword>parecoxib sodium</keyword>
	<keyword>total knee arthroplasty</keyword>
	<keyword>total hip arthroplasty</keyword>
</DOC>